Search
for
Sort by
Research 211–240 of 213
- Stress Related Hair Disorders
- Polycystic ovary syndrome [PCOS]: Comprehensive management in primary care
- Minoxidil
- Skin infections among infants and parental awareness: Is there any relationship?
- Polycystic ovarian syndrome: current understanding of pathogenesis, diagnosis and treatment
- Farmácia Aliança - Maia
- Patterns of Common Dermatological Conditions among Children and Adolescents in Pakistan
- Medicinal plants used in cosmetics for skin and hair care
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Hair Disorders in Autoimmune Diseases
- The Important Role of Leptin in Modulating the Risk of Dermatological Diseases
- Advances in Extraction Technologies of Silybum marianum L. and Its Role in Protecting Against Skin Damage
- Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results
- Finasteride in the treatment of hirsutism: new therapeutic perspectives
- Is seborrhea a sign of autonomic impairment in Parkinson's disease?
- Efficacy and safety of oral minoxidil in female androgenetic alopecia
- Operative transvaginal hydrolaparoscopy improve ovulation rate after clomiphene failure in polycystic ovary syndrome
- Upadacitinib for the management of severe alopecia areata in adolescent patients: a single-centre retrospective study
- Confocal microscopy can assess the efficacy of combined microneedling and skinbooster for striae rubrae
- Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment
- Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism
- Telogen effluvium in the new SARS‐CoV‐2 era
- Trichoscopy of the beard: Aid tool for diagnosis of frontal fibrosing alopecia in men
- Black dots in trichoscopy after COVID‐19. Can it be telogen effluvium?
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
- Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study
- Clinical Efficacy, Cosmetic Acceptability, and Local Tolerability of a New Formulation of Topical 5% Minoxidil without Propylene glycol: A 6-month, Multicentre, Real-life, Prospective, Assessor-Blinded Study in 196 Subjects with Hair Loss. The andldquo;NOMINALandrdquo; Trial
- Treatment of hereditary hypotrichosis simplex of the scalp with oral minoxidil and growth factors